ASGCT Members Speak at House CAR T-Cell Therapy Briefing

Several ASGCT leaders, including President Hans-Peter Kiem, MD, PhD; Board Member Rayne Rouce, MD; and Member Renier Brentjens, MD, PhD, spoke today during the bipartisan House Cancer Caucus briefing on CAR T-cell therapies and patient access.

Agenda 

Thursday, Sept. 29
10 a.m. (ET)

10 a.m.: Welcome and Introductions by House Cancer Caucus Co-Chairs 

10:08 a.m.: Hans Peter-Kiem, MD, PhD 
Topic: Gene and cell therapy basics and the CAR T pipeline

10:15 a.m.: Rayne Rouce, MD 
Topic: The patient experience and delivery of care 

10:25 a.m.: Renier Brentjens, MD, PhD 
Topic:  Expansion of CAR T-cell therapies to solid tumor malignancies 

10:35 a.m.: Rachel Pollock, JD 
Topic: NIH funding 

10:50 a.m.: Q&A